Stimulation site within the MRI‐defined STN predicts postoperative motor outcome

High‐frequency stimulation of the subthalamic nucleus (STN‐HFS) is highly effective in treating motor symptoms in Parkinson's disease (PD) and medication side effects as well as in improving quality of life. Despite preoperative screening for patients as eligible candidates for this treatment, electrode position may furthermore influence treatment quality. Here, we investigated the relationship between the anatomical site of stimulation within the MRI‐defined STN and the outcome of PD patients after STN‐HFS. In 30 PD patients with bilateral STN stimulation, we retrospectively defined the boundaries of the STN within the axial target plane of the stereotactic T2‐weighted MRI and determined the position of the active electrode contact in relation to the border of the STN. The position of the active contact within the STN was the only variable to predict the outcome of STN stimulation. In contrast, covariates such as age, disease duration, symptom severity, and response to levodopa had no effect. The lateral position of the stimulation contact within the STN led to significantly better clinical improvement, lower stimulation parameters, and less need for postoperative dopaminergic medication. The outcome of patients with stimulation contacts within the medial region of the STN was significantly worse. Precise targeting of the lateral region of the STN is essential for achieving sufficient stimulation efficacy. Preoperative T2‐weighted MRI might be a useful component of the targeting procedure to improve the outcome of PD patients. © 2012 Movement Disorder Society

[1]  Didier Dormont,et al.  Is the subthalamic nucleus hypointense on T2-weighted images? A correlation study using MR imaging and stereotactic atlas data. , 2004, AJNR. American journal of neuroradiology.

[2]  Sébastien Ourselin,et al.  A three-dimensional, histological and deformable atlas of the human basal ganglia. I. Atlas construction based on immunohistochemical and MRI data , 2007, NeuroImage.

[3]  P. Remy,et al.  Outcome of Bilateral Subthalamic Nucleus Stimulation in the Treatment of Parkinson’s Disease: Correlation with Intra-Operative Multi-Unit Recordings but Not with the Type of Anaesthesia , 2008, European Neurology.

[4]  M. Delong,et al.  Deep Brain Stimulation for Neurologic and Neuropsychiatric Disorders , 2006, Neuron.

[5]  D. Bowers,et al.  Cognition and mood in Parkinson's disease in subthalamic nucleus versus globus pallidus interna deep brain stimulation: The COMPARE Trial , 2009, Annals of neurology.

[6]  W. Hamel,et al.  Documentation of electrode localization , 2002, Movement disorders : official journal of the Movement Disorder Society.

[7]  J. Volkmann,et al.  Introduction to the programming of deep brain stimulators , 2002, Movement disorders : official journal of the Movement Disorder Society.

[8]  Sheng-Huang Lin,et al.  Prognostic Factors of Subthalamic Stimulation in Parkinson’s Disease: A Comparative Study between Short- and Long-Term Effects , 2009, Stereotactic and Functional Neurosurgery.

[9]  A. Parent,et al.  Functional anatomy of the basal ganglia. II. The place of subthalamic nucleus and external pallidium in basal ganglia circuitry , 1995, Brain Research Reviews.

[10]  Bettina Schrader,et al.  Most effective stimulation site in subthalamic deep brain stimulation for Parkinson's disease , 2004, Movement disorders : official journal of the Movement Disorder Society.

[11]  G. Deuschl,et al.  Subthalamic nucleus deep brain stimulation: Summary and meta‐analysis of outcomes , 2006, Movement disorders : official journal of the Movement Disorder Society.

[12]  G. Deuschl,et al.  A randomized trial of deep-brain stimulation for Parkinson's disease. , 2006, The New England journal of medicine.